BridgeMD
New treatment option for Hodgkin Lymphoma
Official title ATLCAR.CD30.CCR4 for CD30+ HL ATLCAR.CD30.CCR4 Cells
ClinicalTrials.gov ID: NCT06090864
What this study is testing
What is Chemotherapy?
Chemotherapy is an investigational medicine, given as an once-daily infusion into a vein, being studied as a potential treatment for hodgkin lymphoma.
Plain-language explanation of the investigational treatment - it is being studied and is not an approved or proven therapy. The study team can confirm the details.
- What it's testing
- Despite the progress in the therapy, Hodgkin's Lymphoma (HL) remains fatal for more than 15% of patients. Even in patients who are cured, the morbidity of therapy is substantial and long-lasting.
- Phase 2: a mid-size study of how well it works
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- During the period of cell procurement and lymphodepletion, people will be eligible to receive standard-of-care therapy e.g., chemotherapy or...
- Written informed consent and HIPAA authorization for release of personal health information explained to, understood by, and signed by the subject or...
- Age ≥ 18 years at the time of consent.
- Karnofsky score of \> 60%
- The subject must have a diagnosis of Classical Hodgkin Lymphoma according to World Health Organization criteria.
You likely can't join if
- people had major surgery within 28 days.
- Subject received investigational agents or tumor vaccines within 3 weeks.
- Subject received chemotherapy or radiation therapy within the previous 3 weeks.
The study team makes the final eligibility decision.
Where it's taking place
- Chapel Hill, North Carolina, United States
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Chapel Hill, North Carolina, United States. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.